ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease. Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered “undruggable”
Strategies
* Invent and build technologies to unlock first-in-class medicines for the treatment of cancer, rare genetic disorders, and infectious diseases
* Decipher disease relevant structural and functional RNA motifs by integrating human genetic data, functional genomics, and AI
* Integrate Machine Learning tools and advanced the mechanistic understanding of the RNA life cycle at scale in order to deliver transformative therapies for millions of patients
Company Details
- Employees
- 20
- Founded
- -
- Address
- 600 Gateway Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.revirtx.com
- Keywords
- Manager jobs.
- HQ
- South San Francisco, California
Revir Therapeutics Questions
Revir Therapeutics's website is http://www.revirtx.com
Revir Therapeutics's LinkedIn profile is https://www.linkedin.com/company/revir-therapeutics
Revir Therapeutics has
20 employees.
View email and phone details for 20
employees at Revir Therapeutics.
Revir Therapeutics's industry is
Biotechnology Research
Revir Therapeutics's top competitors are
Acrobat Genomics,
Xaira Therapeutics,
Lynx Biosciences, Inc.,
Think Bioscience,
Bitterroot Bio,
Levatio Therapeutics,
Domina Therapeutics,
Iris Medicine,
Promis™ Neurosciences, Inc.,
Chemomab Therapeutics.
Revir Therapeutics's categories are Biotechnology Research
Revir Therapeutics's founding year is 2021
